News

WASHINGTON, January 4, 2004 (LifeSiteNews.com) – A 141-page US Justice Department document dealing with guidelines for treating victims of sexual assault has received criticism from abortion providers for failing to recommend the abortifacient morning-after pill. 

“I think it’s very smart not to put that in the guidelines,” Physicians for Life board member Dr. George Isajiw said.

Giving the morning-after pill to women, he said, is “. . . giving a dangerous drug that’s not doing any good, or else you’re causing an abortion. As a moral principle, a woman has the right to defend herself against an aggressor. But she doesn’t have the right to kill the baby,” according to a Philadelphia Inquirer report. 

New York state has already made it illegal for hospitals to refuse the morning-after pill to rape victims, regardless of religious affiliation. One hospital has already been fined $46,000 for failing to administer the abortifacient. 

The chances of a woman becoming pregnant as a result of sexual assault are roughly five percent, according to Princeton University population researcher James Trussell. 

Last year the US Food and Drug Administration rejected an application from the manufacturer to allow over-the-counter sales of the “Plan B” morning-after pill. The FDA will re-visit the issue in the coming weeks.  tv

Comments

Commenting Guidelines

LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.